Personal and social performance in schizophrenia: double-blind, non-inferiority study of once-monthly vs oral aripiprazole

被引：1
|
作者：
Fleischhacker, W. W. [1 ]
Sanchez, R. [2 ]
Jin, N. [3 ]
Peters-Strickland, T. [2 ]
Johnson, B. R. [4 ]
Eramo, A. [5 ]
Loze, J. Y. [6 ]
McQuade, R. D. [7 ]
Carson, W. H. [8 ]
Kane, J. [9 ,10 ]
机构：
[1] Med Univ Innsbruck, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Austria
[2] Otsuka Pharmaceut Dev & Commercializat Inc, Global Clin Dev CNS, Princeton, NJ USA
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Biostat, Rockville, MD USA
[4] Otsuka Pharmaceut Dev & Commercializat Inc, Clin Management, Princeton, NJ USA
[5] H Lundbeck & Co AS, Med Affairs & Phase Clin Affairs 4, Deerfield, IL USA
[6] Otsuka Pharmaceut Europe Ltd, European CNS Market Access, London, England
[7] Otsuka Pharmaceut Dev & Commercializat Inc, Global Med Regulatory Affairs & Alliances, Princeton, NJ USA
[8] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[9] Zucker Hillside Hosp, Glen Oaks, NY USA
[10] Hofstra North Shore LIJ Sch Med, Dept Psychiat, Glen Oaks, NY USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70751-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.028
引用
收藏
页码：S474 / S475
页数：2
相关论文
共 50 条
  • [1] Aripiprazole once-monthly for schizophrenia: a double-blind, randomised, non-inferiority study versus oral aripiprazole
    Peters-Strickland, T.
    Fleischhacker, W. W.
    Sanchez, R.
    Jin, N.
    Baker, R. A.
    Johnson, B.
    Loze, J. Y.
    McQuade, R. D.
    Carson, W. H.
    Kane, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S473 - S474
  • [2] Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study
    Fleischhacker, W. Wolfgang
    Sanchez, Raymond
    Perry, Pamela P.
    Jin, Na
    Peters-Strickland, Timothy
    Johnson, Brian R.
    Baker, Ross A.
    Eramo, Anna
    McQuade, Robert D.
    Carson, William H.
    Walling, David
    Kane, John M.
    BRITISH JOURNAL OF PSYCHIATRY, 2014, 205 (02) : 135 - 144
  • [3] Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: A multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole
    Ishigooka, Jun
    Nakamura, Jun
    Fujii, Yasuo
    Iwata, Nakao
    Kishimoto, Toshifumi
    Iyo, Masaomi
    Uchimura, Naohisa
    Nishimura, Ryoji
    Shimizu, Naoaki
    SCHIZOPHRENIA RESEARCH, 2015, 161 (2-3) : 421 - 428
  • [4] Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study
    Le Xiao
    Qian Zhao
    An-ning Li
    Jushui Sun
    Bin Wu
    Lina Wang
    Honggeng Zhang
    Ruiling Zhang
    Keqing Li
    Xiaojin Xu
    Tiebang Liu
    Wenshun Zhang
    Shiping Xie
    Xiufeng Xu
    Yunlong Tan
    Kerang Zhang
    Hongyan Zhang
    Nianhong Guan
    Mingji Xian
    Motomichi Uki
    Gang Wang
    Psychopharmacology, 2022, 239 : 243 - 251
  • [5] Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study
    Xiao, Le
    Zhao, Qian
    Li, An-ning
    Sun, Jushui
    Wu, Bin
    Wang, Lina
    Zhang, Honggeng
    Zhang, Ruiling
    Li, Keqing
    Xu, Xiaojin
    Liu, Tiebang
    Zhang, Wenshun
    Xie, Shiping
    Xu, Xiufeng
    Tan, Yunlong
    Zhang, Kerang
    Zhang, Hongyan
    Guan, Nianhong
    Xian, Mingji
    Uki, Motomichi
    Wang, Gang
    PSYCHOPHARMACOLOGY, 2022, 239 (01) : 243 - 251
  • [6] Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study (vol 205, pg 135, 2014)
    不详
    BRITISH JOURNAL OF PSYCHIATRY, 2014, 205 (05) : 412 - 412
  • [7] Efficacy of aripirpazole once-monthly in Asian patients with schizophrenia: Secondary efficacy outcomes in a multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole
    Ishigooka, J.
    Nakamura, J.
    Shimizu, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 62 - 62
  • [8] Effects of aripiprazole once-monthly on domains of personal and social performance: Results from 2 multicenter, randomized, double-blind studies
    Fleischhacker, W. Wolfgang
    Baker, Ross A.
    Eramo, Anna
    Sanchez, Raymond
    Tsai, Lan-Feng
    Peters-Strickland, Timothy
    Perry, Pamela P.
    McQuade, Robert D.
    Johnson, Brian R.
    Carson, William H.
    Kane, John M.
    SCHIZOPHRENIA RESEARCH, 2014, 159 (2-3) : 415 - 420
  • [9] Effects of aripiprazole once-monthly in patients with schizophrenia switched from oral antipsychotics to aripiprazole once-monthly
    Kane, J. M.
    Zhao, C.
    Johnson, B.
    Baker, R. A.
    Eramo, A.
    McQuade, R.
    Duca, A.
    Sanchez, R.
    Peters-Strickland, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S543 - S544
  • [10] PSYCHOSOCIAL AND OVERALL EFFECTIVENESS OF ARIPIPRAZOLE ONCE-MONTHLY VS. PLACEBO ONCE-MONTHLY FOR MAINTENANCE TREATMENT IN SCHIZOPHRENIA
    Baker, R.
    Carson, W. H.
    Perry, P.
    Sanchez, R.
    Jin, N.
    McQuade, R. D.
    Kane, J.
    Fleischhacker, W. W.
    EUROPEAN PSYCHIATRY, 2013, 28
12345